Invesco Ltd. Grows Holdings in Cigna Group $CI

Invesco Ltd. lifted its position in shares of Cigna Group (NYSE:CI) by 15.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,620,938 shares of the health services provider’s stock after buying an additional 222,058 shares during the quarter. Invesco Ltd. owned approximately 0.61% of Cigna Group worth $535,850,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CI. 1832 Asset Management L.P. acquired a new stake in Cigna Group during the second quarter worth approximately $2,516,000. CW Advisors LLC lifted its stake in shares of Cigna Group by 64.0% during the 2nd quarter. CW Advisors LLC now owns 34,675 shares of the health services provider’s stock worth $11,463,000 after purchasing an additional 13,535 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Cigna Group during the second quarter worth $52,000. River Wealth Advisors LLC grew its position in shares of Cigna Group by 2.7% in the second quarter. River Wealth Advisors LLC now owns 2,592 shares of the health services provider’s stock valued at $857,000 after purchasing an additional 67 shares during the period. Finally, Groupe la Francaise purchased a new stake in shares of Cigna Group in the second quarter valued at $5,322,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on CI shares. UBS Group set a $294.00 price target on Cigna Group in a research note on Wednesday, November 12th. TD Cowen cut their price objective on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Robert W. Baird set a $372.00 target price on shares of Cigna Group in a report on Thursday, August 14th. Leerink Partners dropped their price target on shares of Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Finally, Cowen reaffirmed a “buy” rating on shares of Cigna Group in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $334.45.

Cigna Group Trading Down 0.9%

NYSE CI opened at $267.98 on Friday. The firm has a market capitalization of $71.59 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.98 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company’s 50 day moving average price is $283.63 and its 200 day moving average price is $296.31.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm earned $7.51 earnings per share. Cigna Group’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Insider Transactions at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani bought 4,134 shares of the stock in a transaction dated Monday, November 3rd. The stock was bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.